With series of governance issues at Kimia Farma (KAEF) and Indofarma (INAF), some wonder whether it is worth to keep the State’s involvement in the pharmaceutical industry. Still, PT Bio Farma, a holding company for state pharmaceutical firms, is proposing additional state capital placement or injection (PMN) of Rp2.21 trillion for 2025, used for funding the construction of new production facilities, also to upgrading existing machines and technology. To subscribe please click here
